Living With High Altitude Pulmonary Hypertension: An Interview with Karen Terrell

by Jennifer Wolfe, NP-S

During my last week of a clinical rotation at Ebert Family Clinic in Frisco, Colorado, at 9000 feet, I was thrilled to have the opportunity to interview high altitude resident Karen Terrell with physician Dr. Chris Ebert-Santos.  During this time, we were able to discuss high altitude pulmonary hypertension, also known as NAPH. This is a condition that Karen has been living with since 2015.  NAPH is condition that can affect people that live above 8,200 feet, more than 140 million people live at this altitude worldwide, including the population of Summit County, where the town of Frisco, Colorado is. Pulmonary hypertension is a group of disorders that will typically be diagnosed during a heart catheterization measuring the mean arterial pressure of the right side of the heart.  These disorders are broken down into five groups. High altitude pulmonary hypertension is in group three. The primary symptoms that people first notice is extreme fatigue, difficulty getting air upon exertion, and difficulty engaging in their normal exercise routines.

How long have you lived in Summit County [Colorado], and where did you move from originally?

Karen: I grew up in Nebraska, I moved to New York City as soon as I was old enough to leave home.  I went to Boulder for school, and then moved to Denver for work.  I went to an Outward-Bound Experience, and I fell in love with this area.  I have lived in Summit County over 37 years. My kids were born and raised here; they are now in their 30s.

What are some of the things that you love to do in area?

Karen: I downhill ski, I uphill ski, and I cross country ski.  Mountain biking is my passion. I downhill bike, that is where you take the gondola to the top of the mountain and then ride your bike down.

When did you start to have symptoms?

Karen: 2015

What were the symptoms that you noticed first?

Karen: Extreme fatigue and erratic pulse, with or without exertion.  By the end of a run, I would be so exhausted that I was practically crawling home.

Do have to go on oxygen at any point?

Karen: In 2018 I started using oxygen at night. I still use oxygen at night.  In 2020 I started riding and skiing with portable oxygen. When my oxygen columns fail, so do I. It was also during this time I began to work on nasal breathing night and day.  I have been doing research on the importance of nasal breathing and retraining the body on how to take in oxygen.  Practicing nasal breathing is especially important when you are using a nasal cannula to get oxygen when you are being active.

An image of the OxyGo FIT portable oxygen concentrator with specifications.
https://oxygo.life/oxygo-fit

Dr. Chris Ebert-Santos:  The standard is “if you’re 50 and you’ve lived here 10 years and you want to live here for another 10 years you should be sleeping on oxygen.”

Between 2015 and 2018 did you have any other symptoms or worsening concerns?

Karen: In 2017 I applied for life insurance.  I was denied as I had what I now know is chronic proteinuria. The nephrologist was perplexed as to why someone who is as active as I am and takes no medication is having this condition.  The insurance company essentially told me that they would not touch me with a 10-foot pole.  This was the “canary in the mine” that made me think something was not right. In 2018, I had a cardiac ablation. The cardiac ablation corrected the erratic heart rate and relieved my extreme fatigue. However, it did nothing for my oxygen saturation.

You mentioned in 2020 that you started to ski and ride your bike with portable oxygen.  Did something happen in 2020, besides COVID?

Karen: You know, with everything that I have going on health wise I have been so cautious that I have not ever had COVID. In 2020, I was at an office visit with my PA. I mentioned that biking and skiing at higher elevation with exertion, that I felt flattened and near-dead.  My pulse oximeter showed oxygen saturation of low 70’s. My PA freaked out and thought I had Pulmonary Hypertension (as opposed to HAPH) and sent me to a Denver Pulmonary specialist.

What did the pulmonary specialist tell you?

Karen: When I went to the pulmonary specialist, they said my oxygen numbers were fine at Denver’s elevation. The Pulmonologist advised moving to lower elevation but said there is no knowing how low until I experiment.  I have lived in Summit County and raised my children here; my children still live here.  Moving was not an option. I started riding and skiing with portable oxygen. When 02 columns fail, so do I. I do have periodic episodes of extreme joint pain resulting from excessive stress/time at desk (10-hr days).  However, I try to eliminate the pain by remaining active using oxygen when I need it. If I don’t use oxygen to sleep, I feel half dead the next day and it is difficult to wake up the next day.  I worry about the long-term effects of the hypoxia, however I continue to monitor.  I am hoping to see more research done in the area of high-altitude pulmonary hypertension. 

Jennifer Wolfe is in her final semester of Nurse Practitioner school at Georgetown University. She was born and raised in Missouri and attended The University of Missouri where she graduated with a bachelor’s degree in psychology. After attending Mizzou she married her husband who was active duty in the US Navy. They traveled to many bases and had two boys before calling Denver their home in 2011.  Jennifer received her BSN from Denver College of Nursing. Jennifer has spent 7 years as a nurse in the emergency department of several level II trauma centers before starting at Georgetown as a part of the Family Nurse Practitioner program.  Jennifer enjoys spending her free time with her family and their three dogs.  

Maternal Exercise and Its Effect on the Development of High-Altitude Pulmonary Hypertension in Children

by Julia Wu, PA-S

Every newborn I have managed while rotating at Ebert Family Clinic in Frisco, Colorado at 9000′ has needed oxygen supplementation. It is known that at high altitudes, there is a lower oxygen concentration in the air, which poses challenges to our bodies. What exactly happens, and what are the consequences of chronic high-altitude exposure? There are approximately 140 million people that live at high altitudes, defined as at least 2500 meters above sea level, who are affected by chronic hypoxic conditions.1 In this article, I will focus on how hypoxia — low levels of oxygen in the blood — affects pregnant women, alters fetal to newborn transition and development, and whether cardiorespiratory exercise by mothers during pregnancy can prevent diseases such as high-altitude pulmonary hypertension (HAPH) development in offspring.  

Pulmonary hypertension (PH) is abnormally high blood pressure in the pulmonary arteries. PH is classified into 5 groups based on the cause. High-altitude pulmonary hypertension (HAPH) is Group III PH and defined as mean pulmonary arterial pressure (PAP) ≥25 mm Hg. Chronic high-altitude hypoxia can lead to the development of HAPH, which has adverse effects on the heart from right ventricular wall thickening to reduced cardiac output, and eventual right heart failure and death. HAPH can occur in utero, so it’s imperative to understand how hypoxia affects mothers and their fetuses during and after birth.2

During pregnancy, the fetus doesn’t breathe air and the lungs are not used. The fetus receives all its oxygen and nutrition needs from the mother’s blood, which flows through the blood vessels in the umbilical cord to the placenta and then to the baby.3 Circulating blood bypasses the lungs by flowing in different pathways through openings called shunts that close at birth to allow for adult circulation. In utero, the baby’s lungs fill with a special fluid that helps the lungs grow.4 The fluid in the lungs, in combination with naturally thicker pulmonary vascular and pulmonary vessel vasoconstriction from low PO2, causes higher vascular resistance in pulmonary circulation that allows for the diversion of blood away from the lungs through the shunts.2 At low altitudes, in the first few days after birth, the high PAP in the lungs drops. The sharp drop in PAP is due to “expansion of the lungs, pulmonary vasodilation from higher PO2, a gradual receding of fluid, a thinning of pulmonary vascular smooth muscle, and… closing of the [shunts]”. This process is known as cardiopulmonary transition. However, at altitude, perinatal hypoxia negatively affects cardiopulmonary transition. The elevated pressures in the pulmonary arteries and vascular resistance persist into early childhood delaying cardiopulmonary transition, which can have developmental consequences such as HAPH and right heart failure, as discussed.

It was discovered that cardiopulmonary transition delay is linked to a high-altitude hypoxia-induced proinflammatory state within the pulmonary vasculature that leads to pulmonary artery remodeling and HAPH. Hypoxia activates or upregulates transcription factor, nuclear factor kappa-light-chain-enhancer of activated B cells (NK-kB), that signals for inflammatory mediators such as hypoxia-inducible factors (HIF). HIF-1a inhibits mammalian target of rapamycin (mTOR). mTOR signaling has an important role in cell metabolism, cell proliferation, and survival, thus inhibiting mTOR prevents “non-proliferative branching and elongation of conducting airways and fluid removal from the lungs,” which contributes to increases in pulmonary vascular resistance and lung development during the cardiopulmonary transition and the onset of newborn gas exchange. 2,5 HIF also contributes to the uncontrolled proliferation and resistance to apoptosis of pulmonary artery smooth muscle cells (PASMC) which is also a crucial contributing factor to pulmonary vessel wall thickening, pulmonary vascular remodeling, and vascular resistance. 5 Metabolic studies showed that chronic hypoxia not only increased the expression of these proinflammatory molecules and mediators but also reduced anti-inflammatory products like omega-3 fatty acids.2

Studies have shown that cardiorespiratory exercise reduces proinflammatory markers and increases anti-inflammatory stimulus in healthy and HAPH populations.2 However, exercise training is not sufficient to reverse PAH, so we need to prevent HAPH from developing in utero with maternal exercise.  The American College of Obstetrics and Gynecologists (ACOG) recommends resistance training twice a week and moderate-intensity cardiorespiratory training daily for a total of 150 minutes a week. Studies showed that pregnant women who followed this recommendation had a 25% reduced risk of developing conditions like gestational diabetes and hypertension that contribute to compromised uterine blood flow and fetal hypoxic conditions. At low altitudes, exercise by pregnant mothers leads to benefits such as decreased fat mass, leptin, oxidative stress, pulmonary valve defects, aortic valve defects and inflammation, and increased neurogenesis in the fetus. Some animal studies at high altitudes showed that offspring of physically active pregnant rodents also received similar benefits from maternal exercise. The offspring were protected against proinflammatory stressors evidenced by low levels of inflammatory mediators, which protected them against the inflammatory processes that drive pulmonary artery remodeling and pressures that lead to HAPH. Further animal studies should be conducted to further explore the possibilities that maternal exercise can counteract the inflammatory changes and prevent HAPH development in fetus and newborns.

Resources

  1. Mirrakhimov AE, Strohl KP. High-altitude Pulmonary Hypertension: an Update on Disease Pathogenesis and Management. The Open Cardiovascular Medicine Journal. 2016; 10: 19-27. doi: 10.2174/1874192401610010019
  2. Leslie E, Gibson AL, Gonzalez Bosc LV, Mermier C, Wilson SM, Deyhle MR. Can Maternal Exercise Prevent High-Altitude Pulmonary Hypertension in Children?. High Altitude Medicine & Biology. 2023; 24: 1-6. https://doi.org/10.1089/ham.2022.0098
  3. 2023. Blood Circulation in the Fetus and Newborn. Stanford Medicine Children’s Health. https://www.stanfordchildrens.org/en/topic/default?id=blood-circulation-in-the-fetus-and-newborn-90-P02362
  4. 2023. Transient tachypnea- newborn. Icahn School of Medicine at Mount Sinai. https://www.mountsinai.org/health-library/diseases-conditions/transient-tachypnea-newborn#:~:text=As%20the%20baby%20grows%20in,start%20removing%20or%20reabsorbing%20it.
  5. He S, Zhu T, Fang Z. The Role and Regulation of Pulmonary Artery Smooth Muscle Cell in Pulmonary Hypertension. International Journal of Hypertension. 2020; 2020: 1478291. doi: 10.1155/2020/1478291

Training Student Athletes at Altitude: An Interview with Hurdles Coach, Jay Peltier

article by Caitlin De Castro, PA-S

Several students from Summit High School’s Track & Field team attended the Colorado State Track and Field Championships in Lakewood in May, where they competed with top runners across the state. The boys team placed 20th out of 39 teams, and the girls team tied for 9th place out of 40 teams in Class 4A rankings. Throughout the season, many students set new personal records and broke previous school records. 

I had the pleasure of speaking with Summit High School hurdles coach, Jay Peltier, about training young athletes in high altitude. Jay has coached Track & Field for 15 years and has even helped lead some high schools to win state titles. He has trained student athletes in cities close to sea level as well as ones in higher elevation, like Colorado Springs. This is his second season coaching in Summit County. 

Exercising at high altitude can be a challenge due to the decreased oxygen concentration at higher elevations. Because of this, there is reduced oxygen availability to muscles, causing fatigue to occur sooner at lower working rates. Given his experiences coaching at different altitudes, I asked Jay how he has adjusted his training to being at 9,000 ft. He notes that with elevation as high as this, it’s difficult to train hard for long periods. His workouts at high altitude include longer rest times between reps and less volume per workout. For example, one of Jay’s staple workouts for sprinters when he was training at lower elevation included running twelve 200 meter sprints, totaling up to a volume of 2,400 meters. At high altitude, he would decrease the volume to about 1,800 meters. 

I also asked Jay about how competing at track meets at a lower elevation affects athletes that have been living and training at high altitude. Generally, athletes that run events greater than 400 meters should be faster running at lower elevations because there is increased oxygen availability. This is because distance running is a form of aerobic exercise in which the body uses oxygen as the primary source for energy. Sprinters, on the other hand, may not see the same benefit competing at lower elevation because sprinting is a form of anaerobic exercise, where the body relies on burning carbohydrates for energy. Despite this, Jay recognizes that there are many other variables that can affect these high altitude athletes competing at lower elevations, including weather. Jay notes that competing in lower areas, like Denver or Grand Junction, can also be 20 degrees warmer compared to Summit County. Increased temperatures can lead to exhaustion faster, especially for distance runners.  

Jay and his fellow coaches try to tell their athletes after every practice to “Eat right. Sleep right. Drink right.” in order to maximize their workout. This includes getting a good balance of carbs, protein, fruits, and vegetables in their diet to properly fuel their body. He recommends his athletes get at least 9 hours of sleep at night. He notes that sleep deprivation can significantly impact how one trains, especially at altitude. Lastly, he emphasizes to his athletes the importance of staying hydrated. While this is essential for all athletes, the risk of dehydration is higher at altitude. He recommends they drink half their bodyweight in ounces, plus an extra 10 ounces for being at elevation.

Resources

Jones, Cody. “State Champion Again: Summit’s Ella Hagen Wins 1,600-Meter State Title at Final Day of the Colorado State Track and Field Meet.” SummitDaily.Com, 24 May 2023, www.summitdaily.com/news/state-champion-again-summits-ella-hagen-wins-1600-meter-state-title-at-final-day-of-the-colorado-state-track-and-field-meet/. 

Mancera-Soto, Erica M., et al. “Effect of Hypobaric Hypoxia on Hematological Parameters Related to Oxygen Transport, Blood Volume and Oxygen Consumption in Adolescent Endurance-Training Athletes.” Journal of Exercise Science & Fitness, vol. 20, no. 4, 18 Oct. 2022, pp. 391–399, https://doi.org/10.1016/j.jesf.2022.10.003. 

Ileus at Altitude: When Your Gut Blows Up Like a Potato Chip Bag

Myasthenia Gravis (MG) is a condition caused by the production of antibodies that block acetylcholine receptors. This blockade of neuromuscular signaling results in rapid muscular fatigue and weakness. Increased activity tends to worsen muscular issues which usually resolve with rest. Prominent symptoms of MG include drooping eyelids, double vision — OMG (ocular myasthenia gravis)– difficulty swallowing, slurred speech, and shortness of breath. Generally, muscles in the face and throat are considered to be the most commonly impacted by Myasthenia Gravis. However, this condition can affect any muscle group throughout the body (1). Gastrointestinal (GI) manifestations such as abdominal pain, recurrent vomiting, and constipation have been reported by individuals with MG. A case presenting to the Summit Medical Center located at 9,100 feet illustrates an unusually severe manifestation:

A road covered in tire tracks through white snow passes by a blue and red sign for St. Anthony Summit Medical Center and its emergency room, in front of dark green conifer trees that stand out against a snowy mist that settles over a pine-forested mountain background.
St. Anthony Summit Medical Center on Peak One Drive in Frisco, Summit County, Colorado, at the foot of Peak One of the Ten Mile Range, enshrouded in snowy mist.

A 70 year old woman was brought to the emergency department (ED) with severe abdominal and chest pain, concerned that she had a dissecting aortic aneurysm. She reported three previous episodes of severe  pain in the 2 weeks leading up to the ED visit, all starting in the afternoon, increasing to prostration by 5 pm and resolving with bed rest. Past medical history was significant for myasthenia gravis for which she took azathioprine 100 mg BID (twice daily). Two months previously she had a flare with ptosis and double vision, treated with prednisone 40 mg daily. 

Laboratory tests were normal. Imaging showed distended loops of bowel consistent with ileus. She was treated with pain medication and symptoms resolved.

The patient continued to have episodes once or twice a month, including another ED visit, precipitated by treatment with duoneb, which has  anticholinergic activity, a tonic water drink, and guaifenesin, both antimuscarinic substances that interact with the cholinergic receptors in the viscera.. Taking pyridostigmine, a cholinesterase inhibitor, led to resolution within 2 hours, marked by “sparkly” sensations in her arms and legs and reactivation of bowel sounds with flatus. 

An x-ray of a torso showing marked intestinal distention.
CT scan of patient with intestines diffusely distended with bowel gas.

Until recently, GI symptoms were considered rare in myasthenia gravis. Then a case study in 2001 demonstrated that gastric dysmotility was a common feature among individuals with Myasthenia Gravis (2). Among all the motility dysfunction reported, gastroparesis was found to be a common autonomic feature in MG patients (2). Gastroparesis is the slowing or stopping of movement in the GI tract resulting in delayed gastric emptying. Further research demonstrated that intestinal pseudo-obstruction was considered to be one of the most common GI manifestations of individuals with MG(3,4,5).

In 2007 it was demonstrated that receptors in gut muscles were structurally similar to skeletal muscle receptors, indicating that GI motility could be highly impacted by the presence or lack of acetylcholine (6). Considering that antibody production in Myasthenia Gravis Individuals can decrease acetylcholine binding to receptors, the presence of GI symptoms among other autonomic dysfunction symptoms suggests inadequate treatment which can result in a poor prognosis for these individuals (7). 

What was previously considered a rare symptom within a rare condition, is now being proposed as an early identification tool. Taking into account receptor similarity,  GI symptoms can be used as early indicators of myasthenia gravis, specifically gastrointestinal dysmotility (8). The case study showed that MG developed less than a decade after the initial onset of gastrointestinal dysmotility symptoms (8). There is a clear need to identify GI symptoms earlier in MG individuals. This will allow for better treatment and improved long-term health outcomes for these individuals. 

At altitude, the low barometric pressure causes gaseous distension in normal individuals producing increased flatus (see blog on HAFE). Combined with MG, GI manifestations can be even more severe. Medical providers treating residents of  high altitude communities should consider MG in the differential of patients with abdominal complaints and treat recognized MG patients with anticholinesterase medications to control symptoms. None of this patient’s providers were aware of this manifestation of MG, including the neurologist who specializes in MG, the gastroenterologist who performed an  upper endoscopy and colonoscopy, the ED staff, the radiologist and the primary care provider. Patients with MG and their providers need to be aware of medications that interact with the cholinergic receptors in all parts of the body and screen for these as possible precipitators of symptoms outside the classic description of the disease.

Submitted by Ana Campos, PA-S.

References 

1. (NHS) https://www.nhs.uk/conditions/myasthenia-gravis/ 

2. Vernino S, et al. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci. 2001;88(3):187–192.

3. Pande R, Leis AA. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve 1999;22:1600-1602

4. Musthafa CP, Moosa A, Chandrashekharan PA, Nandakumar R, Narayanan AV, Balakrishnan V. Intestinal pseudo-obstruction as initial presentation of thymoma. Indian J Gastroenterol 2006;25:264-265. 

5. Seretis C, Seretis F, Gemenetzis G, Gourgiotis S, Lagoudianakis E, Pappas A, Keramidaris D, Salemis N. Adhesive ileus complicating recurrent intestinal pseudo-obstruction in a patient with myasthenia gravis. Case Rep Gastroenterol. 2012 

6. Mandl, P, Kiss, JP. Role of presynaptic nicotinic acetylcholine receptors in the regulation of gastrointestinal motility. Brain Res Bull. 2007;72:194–200 

7. Putri Aaliyah. Autonomic Dysfunciton. Gastroparesis as autonomic manifestation of myasthenia Gravis: A rare case report. Clinical Neurophysiology. 132: 94-95, 2021 8. Alnajjar, S., Idiaquez Rios, J., Fathi, D., Liu, G., & Bril, V. (2022). Gastrointestinal Dysmotility as the First Manifestation of Myasthenia Gravis. Canadian Journal of Neurological Sciences, 1-2.

8. Alnajjar, S., Idiaquez Rios, J., Fathi, D., Liu, G., & Bril, V. (2022). Gastrointestinal Dysmotility as the First Manifestation of Myasthenia Gravis. Canadian Journal of Neurological Sciences, 1-2.

Mountain People Can Still Get Mountain Sickness: HL-HAPE, a Fourth Type of High Altitude Pulmonary Edema

There are three types of High Altitude Pulmonary Edema (HAPE) recognized in visitors and people living at high altitudes. These include classic HAPE (C-HAPE), which involves an individual that lives at low altitude traveling to high altitude. Re-entry HAPE (RE-HAPE)  is seen in an individual that lives at high altitude who travels to low altitude and then returns to high altitude. And high-altitude resident pulmonary edema (HARPE) which occurs in an individual that lives at high altitude and does not change altitude (Ebert-Santos, Wiley). While these have been extensively studied and are subtypes that people are warned of, a fourth unexpected type of HAPE has been recently described by pediatric pulmonologist Santiago Ucros in Bogota, Columbia at the Universidad de los Andes. (Ucros)

Highlanders HAPE (HL-HAPE) occurs in people that live at high altitude who then travel to higher altitudes. Though most people who live at high altitudes for long periods of time assume they are immune to HAPE, the recognition of HL-HAPE shows this is not the case. One man had a run-in with HL-HAPE during his long-awaited trip to Mt. Kilimanjaro. 

A man wearing a neck gator under a grey baseball cap and dressed in cold-weather jacket and pants sits on a rock next to a tall giant groundsel plant with cushions of dead leaves puffing up heads of light-green leaves before the sloping of the mountain down into a valley with a white cloud floating above it.

A resident of Summit County, Colorado, Jonathan Huffman set out to climb Mt. Kilimanjaro with his wife Katie when he was 37 years old. He is originally from Texas, but has been living in Breckenridge, Colorado, elevation 9,600 ft, for 15 years. In preparation for the climb, he spent the summer hiking multiple fourteen thousand foot peaks in Colorado, trail running at 9,000-12,000 ft, and mountain biking. 

Two people stand smiling toward the camera with an arm around each other, dressed warmly in long pants, thick jackets and hats, one holding a water bottle, standing on an open field of high alpine shrubs with Mt. Kilimanjaro illuminated in the pink light of the sun, streaked with long, narrow clouds in the background

The elevation of Mt. Kilimanjaro is 19,341 feet and the summit generally takes each group anywhere from 5 to 9 days, depending on the route taken. In September, Jonathan and Katie traveled to Tanzania where they spent two days adjusting to jet lag and preparing for their climb. They had chosen to follow the Lemosho Route which is 42 miles long with an elevation gain of 16,000 to 17,000 feet. 

On the first day, Jonathan and his party started at the Lemosho trailhead (7,742 feet) and hiked up 9,498 feet to the first camp. He noticed that his throat felt dry and he found himself having to clear it often. He attributed this symptom to the dusty environment. 

On the second day, he felt as though his body was fighting the dust, which had found its way into his eyes, sinuses, and throat. He also felt extremely fatigued and stated that every action felt more difficult. Though he could tell his body was struggling to adapt, Jonathan continued to push forward with full force. He made it to the second camp at 11,500 feet. 

A group of orange and white panelled tents sit in the shade of a rocky mountain peak streaked with snow, illuminated in sun above the camp against a cloudless blue sky.

“Day three, we went from 11,500 feet to 13,800 feet,” Jonathan recounts. “After we arrived to this camp, our guides offered to allow us to take a break then hike even higher. This was [an] optional acclimatization test … but I actually skipped it. I was so tired when I got to camp on this day, I decided to just nap in the tent until dinner time.”

On the fourth day, Jonathan’s group hiked up an overpass to Lava Tower located at 15,190 feet. This was also an altitude test, and he passed. He stated that this was the highest he had ever climbed, but that he was beginning to feel more like his normal self. The group stopped for lunch at the tower, but he did not have much of an appetite. He ate the food anyways at the insistence of the guides. 

A sea of clouds illuminated in blues and soft pinks stretches out behind several tents pitched over a shaded, rocky mountain slope in the foreground.

“Then after lunch, we descended down to Barranco Camp [from 15,190 feet to 13,044 feet] and this is where I realized I had HAPE.”

As they were nearing the camp, he felt fluid building in his lungs that was easy to cough up. By the evening, however, he felt as though he was drowning and was unable to lay down. While the guides encouraged him to immediately hike down, he did not want to hike in the dark. He spent the night propped up on duffle bags or sitting in a kitchen chair, with his oxygen reaching as low as 67% at one point. 

Two people sit in the dark of a tent, one with an oxygen mask on and a red head lamp illuminating tin food containers and medical supplies in the foreground as he is administered oxygen.

In the morning, he received 30 minutes of oxygen treatment before beginning his 8-hour descent. His symptoms improved when he reached 6,500 feet. He was picked up in a rescue vehicle and received further treatment at a hospital in Moshi. While he made a full recovery, he stated that he still felt the effects of HAPE while exercising in Colorado at times, up to months after the experience. While Jonathan was only about 2 days away from the summit, he knew that turning back was the best choice. He plans to re-attempt the climb in a few years. 

Jonathan’s story serves as an important reminder to those living at altitude that HAPE can affect anyone. Jonathan’s wife Katie along with everyone else in the group also experienced mild symptoms of altitude sickness including headaches. Research still needs to be conducted on the cause and prevention of this condition in all types. While this shouldn’t stop hikers and climbers from climbing mountains, they should be aware of the signs and symptoms of HAPE, when to seek treatment, and the best ways to prevent it from occurring. 

A map of the Lemosho route as listed on the Ultimate Kilimanjaro guide site can be found here.

A group of people in bright colored pants, jackets and backpacks make their way down a red dirt trail surrounded by tall green grasses and trees extending over a white SUV with a red cross symbol on it in the background down the road.
A man in a beige baseball cap takes a selfie with three men in hats and jackets behind him smiling toward the camera with a white jeep labelled with a red cross in the background behind them.

HAFE: High-Altitude Flatus Expulsion

Often, at high altitude we hear complaints of gas pain and increased flatus in our infant population. Parents often wonder, are we doing something wrong? Is my child reacting to breastmilk, or showing an intolerance to certain foods?  Actually there is another explanation for increased flatus and gas pain in the high-altitude region of Colorado. 

The term HAFE was coined by Dr. Paul Auerbach and Dr. York Miller and published in the Western Journal of Medicine in 1981. Their discovery began In the summer of 1980, when the two doctors were hiking in the San Juan Mountains of Colorado on a quest to summit three 14ers. During their ascent they noticed that something didn’t smell right! As the pair continued to emit noxious fumes, they began to put their scientific brains to work and discovered HAFE. The symptoms include an increase in frequency and volume of flatus, or in other terms an increase in toots! We all have familiarity in watching our bag of potato chips blow up when reaching altitude or our water bottle expanding as we head into the mountains. This reaction is due to a decrease in barometric pressure. Based on Boyle’s law, decreased barometric pressure causes the intestinal gas volume to expand, thus causing HAFE (Skinner & Rawal, 2019).

A graphic illustrating how Boyle's law works: the pressure of a gas increases as its volume decreases.

To my surprise, a gas bubble the size of a walnut in Denver, Colorado (5280 ft) would be the size of a grapefruit in the mountain region of Summit County, CO (8000+ ft)! Trapped gas is known to lead to discomfort and pain. The use of simethicone may have merit in mitigating the effects of HAFE. Simethicone works by changing the surface tension of gas bubbles, allowing easier elimination of gas. This medication, while benign, can be found over the counter and does not appear to be absorbed by the GI tract (Ingold, C. J., & Akhondi, H., 2022). 

While this phenomenon may not be as debilitating as high-altitude pulmonary edema (HAPE), it deserves recognition, as it can cause a significant inconvenience and discomfort to those it inflicts. As the Radiolab podcast explained in their episode The Flight Before Christmas , expelled gas in a plane or car when driving up to the mountains can be embarrassing. While HAFE can be inconvenient, it is a benign condition and a matter of pressure changes rather than a disease or pathological process. We would love to talk more about HAFE at Ebert Family Clinic if you have any questions or concerns!

A bald eagle flies over a misty settled into the valley against the blue-green pine forest of a mountain.
A bald eagle flies toward its nest atop a bare lodgepole pine.

As always, stay happy, safe, and healthy 😊

References

Auerbach, P. & Miller, Y. (1981). High altitude flatus expulsion. The Western Journal of Medicine, 134(2), 173-174.

Chemistry Learner. (2023). Boyle’s Law. https://www.chemistrylearner.com/boyles-law.html

Ingold, C. J., & Akhondi, H. (2022). Simethicone. StatPearls Publishing. 

McKnight, T. (2023). The Flight Before Christmas [Audio podcast]. Radiolab. https://radiolab.org/episodes/flight-christmas

Skinner, R. B., & Rawal, A. R. (2019). EMS flight barotrauma. StatPearls Publishing. 

Re-Entry HAPE: Leading Cause of Critical Illness in Mountain Teens

Health care providers and people who live at altitude often believe that living in the mountains protects from altitude related illness. And yes, there are many ways the body acclimatizes over days, weeks, months, and years, as addressed in previous blog entries. However, as a physician who has practiced in high altitude communities for over 20 years, my personal observation that we are still at risk for serious complications was reenforced by a recent publication by Dr. Santiago Ucrós at the Universidad de los Andes School of Medicine in Santa Fe de Bogotá, Colombia. His article, High altitude pulmonary edema in children: a systemic review, was published in the journal Pediatric Pulmonology in August 2022. He included 35 studies reporting 210 cases, ages 0-18 years, from 12 countries.

A chart titled "HAPE in Children" illustrates cases of high altitude pulmonary edema by country.

Consistent with our experience in Colorado, the most common ages were 6-10 years and second most common 11-15 years. I have not seen or read any reports of adults affected. Cases included two deaths, which I have also seen here.

I receive reports on any of my patients seen in urgent or emergency care. Accidents, avalanches, and suicide attempts are what we think of first needing emergency care in the mountains. However, the most common critical condition is Reentry HAPE. This is a form of pulmonary edema that can occur in children who are returning from a trip to lower altitude. Think visiting Grandma during school break.  Dr. Ucrós’ review also confirms that all presentations of HAPE (classic, as in visitors, reentry, and HARPE, resident children with no history of recent travel) are more common in males by a 2.6 to 1 ratio. Analysis of time spent at lower altitude before the episode showed a range of 1.6 to 30 days with a mean of 11.3 days. Mean time between arrival and onset of symptoms for all types of HAPE was 16.7 hours. The minimum altitude change reported in a HAPE case was 520 meters (1700 feet), which is the difference between Frisco, CO (Summit County) and Kremmling, CO (Grand County, the next county over). A new form of HAPE in high altitude residents who travel to higher altitude was designated HL-HAPE in this review.  A case report will be featured in an upcoming blog interview with a Summit County resident who traveled to Mt. Kilimanjaro.

As with all cases of HAPE, the victims develop a cough, sound congested as the fluid builds up in their lungs, have fatigue, exercise intolerance, with rapid onset over hours of exposure to altitude, usually above 8000 ft or 2500m. Oxygen saturations in this paper ranged from 55 to 79%. My patients have been as low at 39% in the emergency room.  Children presenting earlier or with milder cases come to the office with oxygen saturations in the 80’s. An underlying infection such as a cold or influenza is nearly always present and considered a contributing factor. Everyone living or visiting altitude should have an inexpensive pulse oximeter which can measure oxygen on a finger. Access to oxygen and immediate treatment for values under 89 can be life-saving.

The recurrence rate for all types of HAPE is about 20%. Most children never have another episode, but some have multiple. Preventive measures include slower return to altitude, such as a night in Denver, acetazolamide prescription taken two days before and two days after, and using oxygen for 24-48 hours on arrival. Most families learn to anticipate, prevent, or treat early and don’t need to see a health care provider after the first episode.

On January 26, 2023 I met with Dr. Ucrós and other high altitude scientists including Dr. Christina Eichstaedt, genetics expert at the University of Heidelberg in Germany, Dr. Deborah Liptzen, pediatric pulmonologist, and Dr. Dunbar Ivy, pediatric cardiologist, both from the University of Colorado and Children’s Hospital of Colorado, and Jose Antonio Castro-Rodríguez MD, PhD from the Pontifica Universidad Católica in Santiago de Chile.

We discussed possible genetic susceptibility to HAPE and hypoxia in newborns at altitude with plans to conduct studies in Bogotá and Summit County, Colorado.

Are Epigenetics the Bridge to Permanent Physiologic Adaptations in Organisms Living at High Altitude?

The CDC defines epigenetics as “the study of how your behaviors and environment can cause changes that affect the way your genes work… epigenetic changes are reversible and do not change your DNA sequence, but they can change how your body reads a sequence.”1 Examples of epigenetic changes include methylation, histone modifications, and non-coding RNAs. Researchers have postulated the involvement of epigenetics in an organism’s adaptations to hypoxic high-altitude environments. After looking into this topic, I questioned if epigenetics may be the bridge to the permanent physiologic alterations in organisms living at high altitudes. 

Hypoxia Inducible Factor-1 (HIF-1) is a nuclear transcription factor activated in hypoxia states, and regulates several oxygen-related genes. The role of epigenetics, specifically methylation of HIF-1 in the expression of the erythropoietin gene, in states of hypoxia was researched. Erythropoietin was chosen due to it being a widely known protein that stimulates erythropoiesis in states of hypoxia. It was confirmed that HIF-1 binds to a HIF-1 binding site (HBS) on the erythropoietin enhancer and will induce transcription of erythropoietin.2 CpG methylation in the HBS interferes with HIF-1 binding, thus inhibiting the activation of transcription of erythropoietin.2  They also found that there were several other oxygen-related genes that were susceptible to similar epigenetic changes.2 Another study investigating HIF-1 and its binding to HIF-1 response element (HRE) upstream to a target gene confirmed the potential for epigenetic changes, specifically methylation. They found that this HIF-1 binding site has a CpG dinucleotide, making it inherently susceptible to methylation.To clarify, the most notable epigenetic change is the methylation of cytosine located 5’ to guanine, known as CpG dinucleotides.Again, they reported that methylation of the CpG island in the HIF-1 binding site upstream of the target gene, erythropoietin, was negatively correlated with its expression.

Furthermore, research on epigenetic changes in rats exposed to long and short-term intermittent hypoxic environments and their room air recovery treatments suggests there is a long-term effect in rats exposed to long-term intermittent hypoxia.4  Rats were exposed to short-term (10 days) and long-term (30 days) intermittent hypoxia resembling obstructive sleep apnea oxygen profiles.The short-term hypoxic rats treated for 10 days at room air reversed their altered carotid body reflexes including hypertension, irregular breathing, and increased sympathetic tone. While the long-term hypoxia rats treated for 30 days at room air did not have a reversal of altered carotid body reflexes.There were similar results in reactive oxygen species (ROS) and antioxidant enzyme (AOE) levels. The long-term hypoxia rats had increased levels of ROS and decreased AOEs in their recovery periods compared to the short-term hypoxia rats.

Erythropoietin is not the only oxygen-related gene that is affected. For example, a study looked at the methylation profiles of Tibetan and Yorkshire pigs under high-altitude hypoxia. IGF1R and AKT3 were two notable differentially methylated genes found to have high expression and low methylation levels in Tibetan pigs that suggest a role in adaptation to hypoxic environments.Both genes are responsible for cell proliferation and survival.Tibetan pigs are known to have become physiologically adapted to their high-altitude hypoxic environment over generations and epigenetic changes were verified in the genome-wide sequence ran in this study.5 This study alludes that epigenetics is not only a bridge but may be a part of the permanent physiologically selected adaptations to ensure survival at high altitudes.

In conclusion, research demonstrates a variety of epigenetic changes that are taking place in these high-altitude hypoxic environments. The research suggests that they may likely be tissue-specific as well. There are definite knowledge gaps in the exact roles that epigenetics may play in hypoxic environments and gene expression. There is room for more research and identifying alterations to epigenetics to improve human physiologic adaptations to hypoxia. 

References 

1. Centers for Disease Control and Prevention. What is Epigenetics. https://www.cdc.gov/genomics/disease/epigenetics.htm. Accessed December 30th, 2022.

2. Wenger, R.H., Kvietikova, I., Rolfs, A., Camenisch, G. and Gassmann, M. (1998), Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. European Journal of Biochemistry, 253: 771-777. https://doi.org/10.1046/j.1432-1327.1998.2530771.x

3. Yin H, Blanchard KL. DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms [published correction appears in Blood 2000 Feb 15;95(4):1137]. Blood. 2000;95(1):111-119.

4. Nanduri J, Semenza GL, Prabhakar NR. Epigenetic changes by DNA methylation in chronic and intermittent hypoxia. Am J Physiol Lung Cell Mol Physiol. 2017;313(6):L1096-L1100. doi:10.1152/ajplung.00325.2017

5. Zhang B, Ban D, Gou X, et al. Genome-wide DNA methylation profiles in Tibetan and Yorkshire pigs under high-altitude hypoxia. J Anim Sci Biotechnol. 2019;10:25. Published 2019 Feb 5. doi:10.1186/s40104-019-0316-y

A woman in a white coat with long, dark, straight hair below her shoulders smiles.

Emily Paz is a third-year medical student at Rocky Vista University College of Osteopathic Medicine and is looking forward to pursuing a career in orthopedics. She is from the central coast of California and earned her Bachelor of Science degree in General Biology from the University of California San Diego. She worked in an emergency department as an EMT after her undergraduate education which reaffirmed her passion and curiosity for medicine. In her free time, she enjoys snowboarding, practicing Muay Thai, cooking, and spending time with family and friends.

When Altitude gets High, does Stroke get higher?

Does altitude increase or decrease risk of strokes? As one review put it, “Due to limited literature, lack of large series, and controlled studies, the understanding of stroke at high altitude is still sketchy and incomplete”. What is clear is that stroke at high altitude can often be misdiagnosed (or underdiagnosed), due to the similarity of initial presentation with high altitude cerebral edema (HACE). Both conditions present with imbalance or ataxia, and both can present with focal neurological deficits.  There are few large urban populations at high altitude (Addis Ababa in Ethiopia is 7,726 ft), so medical providers have fewer resources.  Without the ability to perform neuroimaging with a CT scan or MRI in a timely manner a diagnosis of HACE vs. stroke could be uncertain. HACE often causes global cerebral dysfunction, differentiating it from an early stroke before the onset of focal symptoms can and often does prove challenging. 

While the prevalence of strictly hemorrhagic and ischemic strokes at high altitude remains murky, it is known that exposure to high altitude can result in conditions such as TIA, cerebral venous thrombosis (CVT), seizures, and cranial nerve palsies. Most of the research that has been done on strokes is focused on “moderate” and “high” altitudes, as opposed to “very high” or “extremely high” altitudes. As such, there is very little research on populations living at 3500m or higher. There was at least one tangible piece of evidence indicating that the higher the elevation, the earlier the mean onset of stroke – Dhiman et al. (2018) found that at an elevation of 2,000m, the mean age of onset of stroke was 62 years. The age decreased to a mean of 57.9 years at 2,200m in another study (Mahajan et al. (2004)). Yet another study (Razdan et al. (1989)) found 10.9% of the patients in their sample suffered strokes aged < 40, though this was at an altitude of only 1,530m. Some reports suggest higher stroke prevalence at higher altitudes, and at a strikingly young age – between age 20 and age 45.

Student presentation on stroke at altitude at Colorado Medical Society meeting 2022

There have been mixed results on the effect that altitude has on strokes. One systematic review study found 10 studies displaying an increase in stroke prevalence with higher altitude, 5 other studies showing that altitude was actually protective against stroke, and 2 studies in which the results were ambiguous. This study and other sources alluded to the fact that poorer stroke outcomes at higher altitude may be due to polycythemia and increased viscosity of blood. Specifically, Ortiz-Prado et. al noted that “living in high-altitude regions (>2500m) increases the risk of developing thrombosis through hypoxia-driven polycythaemia which leads to a hypercoagulation unbalance”, which was associated with increased risk for stroke. Ortiz-Prado et. al noted that most of their info came from “very few cross-sectional analyses”. These analyses did find “a significant association between living in high-altitude regions and having a greater risk of developing stroke, especially among younger populations”. When the effects of altitude on stroke were broken down by race (Gerken, Huber, Barron, & Zapata, 2022) it was found to be protective in some populations (Whites, African Americans), but detrimental in other populations (Hispanics, Asian-Pacific, and American-Indian). Going back to the work of Ortiz-Prado et. al, altitude increased the risk of stroke at elevations above 3500m, when the time spent at this elevation was at least 28 days, and more so in younger persons (below the age of 45). At lower elevations, between 1500m and 3500m, increased / easier acclimatization and adaptation to hypoxia seemed to offer protective effects against the risk of stroke. Chronic exposure to hypoxia at high altitude triggers adaptive / compensatory mechanisms, such as higher pulmonary arterial flow and improved oxygen diffusing capacity. Ortiz-Prado et. al concluded that a window of ideal elevation seems to exist – below an altitude of 2000m the adaptive mechanisms do not seem to be sufficient to yield a protective effect – however, above 3500m, adaptive mechanisms may actually become maladaptive (excessive polycythemia & blood stasis), yielding a higher risk for stroke. A lack of any adaptation (i.e. in altitude naïve persons) was even more detrimental at such high altitudes, with the authors concluding that “above 3500–4000m, the risk of developing stroke increases, especially if the exposure is acute among non-adapted populations” (Ortiz-Prado et. al, 2022).

Strokes are more common in males compared to females, and this held true at altitudes of 3380m, 4000m, and 4572m. In addition to the standard vascular risk factors such as hypertension, smoking, and diabetes, the higher incidence of polycythemia in persons living at high altitude is thought to play a role. One study (Jha et al. (2002)) found that 75% of the patients in their sample who had suffered strokes had some form of polycythemia – this was at an altitude of 4270m. (Dr. Christine Ebert-Santos of Ebert Family Clinic in Frisco, Colorado at 2743m suspects everyone who lives at altitude has polyerythrocythemia as more accurately described by Dr. Gustavo Zubieta-Calleja of La Paz, Bolivia at 3625m.)

Only about 2% of the world’s population resides at what is considered “high altitude”. Given the current world population (over 8 billion, 5 million), that is still over 160,100,000 people. The sheer number of people that may be at increased risk of stroke is all the more reason for us to act, and act soon, to get more research done. This is further exemplified by the fact that “cerebrovascular events or stroke is the second leading cause of death worldwide, affecting more than 16 million people each year” (Ortiz-Prado et. al). Guidelines need to be implemented to assist in the diagnosis and treatment of stroke at high altitude, to help differentiate it from related conditions such as HACE, giving patients the standard of care that they need and deserve. While a fascinating topic, stroke seems to be delegated to the sidelines in the mountains, cast aside by culprits such as HAPE, HACE, altitude sickness, and hypoxia. More research, more resources, and more funding need to be funneled into understanding stroke at higher altitudes. Overall, it is clear living at or even exposure to higher altitudes can result in a multitude of neurological symptoms, and that a higher incidence of stroke may yet be one of them.

References

Maryam J. Syed, Ismail A. Khatri, Wasim Alamgir, and Mohammad Wasay. Stroke at Moderate and High Altitude. High Altitude Medicine & Biology.Mar 2022.1-7. http://doi.org.mwu.idm.oclc.org/10.1089/ham.2021.0043

Current World Population – https://www.worldometers.info/world-population/ 

Ortiz-Prado E, Cordovez SP, Vasconez E, Viscor G, Roderick P. Chronic high-altitude exposure and the epidemiology of ischaemic stroke: a systematic review. BMJ Open. 2022;12(4):e051777. Published 2022 Apr 29. doi:10.1136/bmjopen-2021-051777

Gerken, Jacob (MS), Huber, Nathan (MS), Barron, Ileana (MD, MPH-S), Zapata, Isain (PhD). “Influence of Elevation of Stroke and Cardiovascular Outcomes”. Poster presented at a conference in Colorado, in 2022.

Links

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058702/ https://www-liebertpub-com.mwu.idm.oclc.org/doi/full/10.1089/ham.2021.0043

Born in Salt Lake City, Utah, Piotr Poczwardowski has also lived in Upstate New York, Florida, and Colorado (where he spent the 13 years prior to moving to Glendale for PA school). While attending the University of Denver, he volunteered at a nearby hospital Emergency Department, and also participated in a study abroad program in Italy. After earning a degree in Psychology, he worked as both a Primary Care Medical Scribe and Neurology MA. His main hobbies include skiing, watching movies, hiking, swimming, playing video games, reading, and playing ping pong. Piotr has also volunteered at the Sky Ridge Medical Center Emergency Department and secured a job as a Primary Care Medical Scribe after graduating from the University of Denver in 2018. Piotr is now attending Midwestern University’s PA program in Glendale, AZ.

Going Home to the Mountains Can Be Dangerous: Re-Entry HAPE (High Altitude Pulmonary Edema)

Louie was excited to get out on the slopes after spending Thanksgiving with family in Vermont. He got tired early and felt his breathing was harder than usual, leaving early to go home and rest. As a competitive skier he thought that was strange. But he was getting over a cold. He could not have imagined that in 24 hours he would be in the emergency room, fighting for his life.

Louie experienced a dangerous condition, set off by altitude, and inflammation from his “cold”, that caused his lungs to fill with fluid.  His oxygen saturation was 54 % instead of the normal 92, he had been vomiting and feeling very weak and short of breath. His blood tests showed dehydration, hypoxemia and acute kidney injury. His chest x-ray looked like a snowstorm. He was transferred to Children’s Hospital in Denver and admitted to the intensive care unit.

The diagnosis of Re-entry HAPE was confirmed by echocardiogram showing increased pressures in his lungs. He improved rapidly with oxygen and low altitude.

Re-entry HAPE is not rare, affecting several Summit County children every year.  Many do not come to medical attention because after their first episode parents carefully monitor their oxygen and have a concentrator available in their home when they return from travel. 

Medical providers may not be aware of this risk, expecting that children living at altitude are acclimatized. (See previous blog entry on Acclimatization vs. Adaptation, April 17, 2019) Re-entry HAPE seems to occur mostly in children between the ages of 4 and 15. Inflammation, such as a viral respiratory infection, seems to play a role.  Trauma may also predispose a returning resident to Re-entry HAPE, as described in our blog post from February 5, 2018, Re-entry HAPE in High Altitude Residents.

Louie agreed to share his story on our blog to help educate medical personnel and families living in the mountains about this dangerous condition. Further research will help define who is at risk.  The University of Heidelberg recently published an article on the genetics of pulmonary hypertension (HARPE is the New HAPE) and is interested in testing families here who have had more than one person affected by HAPE.

Information and discussion for visitors and residents at high elevations.